Dipeptidyl peptidase-4 inhibitors (DPP-4is) improve glucose control in patients with type 2 diabetes mellitus (DM); however, only few studies were properly designed to evaluate their cardiovascular (CV) effects. The purpose of this study was to assess the impact of DPP-4i treatment on CV morbidity and mortality.
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis / Savarese, Gianluigi; PERRONE FILARDI, Pasquale; D'Amore, Carmen; Vitale, Cristiana; Trimarco, Bruno; Pani, Luca; Rosano, Giuseppe M. C.. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 181:(2015), p. 239-44. [10.1016/j.ijcard.2014.12.017]
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis
SAVARESE, GIANLUIGI;PERRONE FILARDI, PASQUALE;D'AMORE, CARMEN;TRIMARCO, BRUNO;
2015
Abstract
Dipeptidyl peptidase-4 inhibitors (DPP-4is) improve glucose control in patients with type 2 diabetes mellitus (DM); however, only few studies were properly designed to evaluate their cardiovascular (CV) effects. The purpose of this study was to assess the impact of DPP-4i treatment on CV morbidity and mortality.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
